A Phase 1 Study of the Clinical and Immunologic

Project: Research project

Project Details

Description

A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803, a Novel Recombinant IL-15 Complex in Patients with Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
StatusFinished
Effective start/end date7/1/1612/31/19

Funding

  • Fred Hutchinson Cancer Research Center

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.